These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 1341665)

  • 1. [The economic evaluation of the early diagnosis of breast carcinoma: a review of the literature].
    Vanara F
    Epidemiol Prev; 1992 Dec; 14(53):22-31. PubMed ID: 1341665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
    Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
    J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic considerations in breast cancer screening of older women.
    Brown ML
    J Gerontol; 1992 Nov; 47 Spec No():51-8. PubMed ID: 1430883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
    Hristova L; Hakama M
    Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.
    Manser R; Dalton A; Carter R; Byrnes G; Elwood M; Campbell DA
    Lung Cancer; 2005 May; 48(2):171-85. PubMed ID: 15829317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Economic evaluation of the new national breast cancer screening programme in France: application to the Bouche-du-Rhone district].
    Giorgi R; Reynaud J; Wait S; Seradour B
    Bull Cancer; 2005 Nov; 92(11):995-1001. PubMed ID: 16316834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identifying and controlling for program-level differences in comparative cost analysis: lessons from the economic evaluation of the National Breast and Cervical Cancer Early Detection Program.
    Subramanian S; Ekwueme DU; Gardner JG; Bapat B; Kramer C
    Eval Program Plann; 2008 May; 31(2):136-44. PubMed ID: 18359084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Economic approach to breast cancer screening in Belgium].
    Autier P; Grivegnée AR
    Rev Med Brux; 1995; 16(4):326-9. PubMed ID: 7481252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost analysis of the National Breast and Cervical Cancer Early Detection Program: selected states, 2003 to 2004.
    Ekwueme DU; Gardner JG; Subramanian S; Tangka FK; Bapat B; Richardson LC
    Cancer; 2008 Feb; 112(3):626-35. PubMed ID: 18157831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Economic evaluation of screening for neuroblastoma].
    Lacour A; Chauvin F; Duru G; Philip T
    Rev Epidemiol Sante Publique; 1994; 42(1):24-33. PubMed ID: 8134663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simulation modeling of change to breast cancer detection age eligibility recommendations in Ontario, 2002-2021.
    Hunter DJ; Drake SM; Shortt SE; Dorland JL; Tran N
    Cancer Detect Prev; 2004; 28(6):453-60. PubMed ID: 15582269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cost-effectiveness of mammography screening in Norway].
    Kåresen R; Bø JK; Haustveit S; Hervik A; Thoresen SO
    Tidsskr Nor Laegeforen; 1999 Oct; 119(24):3553-9. PubMed ID: 10563171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developing and testing a cost-assessment tool for cancer screening programs.
    Subramanian S; Ekwueme DU; Gardner JG; Trogdon J
    Am J Prev Med; 2009 Sep; 37(3):242-7. PubMed ID: 19666160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A model-based comparison of breast cancer screening strategies: mammograms and clinical breast examinations.
    Shen Y; Parmigiani G
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):529-32. PubMed ID: 15734983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost effectiveness of breast cancer screening with contrast-enhanced MRI in high-risk women.
    Taneja C; Edelsberg J; Weycker D; Guo A; Oster G; Weinreb J
    J Am Coll Radiol; 2009 Mar; 6(3):171-9. PubMed ID: 19248993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Economic approach to breast cancer screening in Belgium].
    Grivegnée AR; Autier P
    Rev Med Brux; 2001 Sep; 22(4):A277-81. PubMed ID: 11680188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic evaluation of health services. Concepts and methodology applied to screening programmes.
    Griffiths DA
    Rev Epidemiol Sante Publique; 1981; 29(1):85-101. PubMed ID: 6789412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A literature review of assumptions on test characteristics and adherence in economic evaluations of colonoscopy and CT-colonography screening.
    van Gils P; van den Berg M; van Kranen H; de Wit AG
    Eur J Cancer; 2009 Jun; 45(9):1554-9. PubMed ID: 19261464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A workplace breast cancer screening program. Costs and components.
    Schrammel P; Griffiths RI; Griffiths CB
    AAOHN J; 1998 Nov; 46(11):523-9. PubMed ID: 9934000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating personal costs incurred by a woman participating in mammography screening in the National Breast and Cervical Cancer Early Detection Program.
    Ekwueme DU; Hall IJ; Richardson LC; Gardner JG; Royalty J; Thompson TD
    Cancer; 2008 Aug; 113(3):592-601. PubMed ID: 18536027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.